Gilead Sciences Inc. has developed Sovaldi, an FDA-approved, once-daily pill that has dramatically improved the odds of beating Hepatitis C. Although millions of people could likely benefit… Read More
Learn more about the costly advances in Hepatitis C treatment, and the ethical dilemma it now poses for eradicating the virus from infected prisoners Read More
Being cured of Hepatitis C is an exciting and more frequent occurrence thanks to improvements in antiviral therapy; however, caring for your liver afterwards is important for the liver&rsquo&hell…Read More
AbbVie Inc. is one step closer to marketing its two-drug combination for the treatment of Hepatitis C Read More
Subscribe to News | Hepatitis Central
Get updates delivered right to your inbox!